Determination of effective therapeutic regimen via Levamisole in controlling the idiopathic nephrotic syndrome relapse among childre
Phase 1
Recruiting
- Conditions
- Pediatric Nephrotic Syndrome.Nephrotic syndrome
- Registration Number
- IRCT20180519039715N3
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 188
Inclusion Criteria
Patients affliction with steroid-dependent idiopathic nephrotic syndrome or with high number of relapses
2-15 years old
non-use of steroid supplementation
Exclusion Criteria
Patient treatment with Levamisole for less than 4 months (the minimum follow-up period)
the children’s affliction with any chronic disease other than nephrotic syndrome
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence of Pediatric Nephrotic Syndrome. Timepoint: 4 Weeks. Method of measurement: Three-plus Proteinuria (measured by a special tape that contains protein indicator; three-plus and higher is considered relapse) on three consecutive days at the end of each month.
- Secondary Outcome Measures
Name Time Method Dose of corticosteroid. Timepoint: 4 Weeks. Method of measurement: Laboratory results and clinical evaluation.;Drug side effects. Timepoint: 4 Weeks. Method of measurement: Ask the patient or his legal guardian, as well as laboratory results and clinical evaluations.